financetom
Business
financetom
/
Business
/
Doordash Insider Sold Shares Worth $9,269,921, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Doordash Insider Sold Shares Worth $9,269,921, According to a Recent SEC Filing
Apr 3, 2024 2:02 PM

04:35 PM EDT, 04/03/2024 (MT Newswires) -- Andy Fang, Director, on April 01, 2024, sold 67,000 shares in Doordash ( DASH ) for $9,269,921. Following the Form 4 filing with the SEC, Fang has control over a total of 36,482 shares of the company, with 36,482 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1792789/000141588924010006/xslF345X03/form4-04032024_080421.xml

Price: 138.64, Change: -0.14, Percent Change: -0.1

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BP to sell its US onshore wind business
BP to sell its US onshore wind business
Sep 16, 2024
* BP to integrate onshore renewable power into Lightsource bp * Says sale process to start shortly (Adds detail from statement and background throughout) Sept 16 (Reuters) - BP plans to sell its U.S. onshore wind energy business, it announced on Monday, saying the assets were not aligned with its growth plans. BP said it will launch the sale process...
Nuvalent Says 2 Potential Lung Cancer Drugs Show 'Favorable Tolerability'
Nuvalent Says 2 Potential Lung Cancer Drugs Show 'Favorable Tolerability'
Sep 16, 2024
10:11 AM EDT, 09/16/2024 (MT Newswires) -- Nuvalent ( NUVL ) said Saturday that data from the ongoing parallel phase 1/2 trials of zidesamtinib and NVL-655 to treat patients with non-small cell lung cancer showed favorable tolerability. The biopharmaceutical company said the studies have established preliminary clinical proof-of-concept for zidesamtinib and NVL-655 as TRK-sparing TKIs that have the potential to...
Carl Icahn welcomes dismissal of Icahn Enterprises lawsuit, not selling shares
Carl Icahn welcomes dismissal of Icahn Enterprises lawsuit, not selling shares
Sep 16, 2024
(Reuters) - Carl Icahn said on Monday he was pleased a federal judge dismissed a lawsuit accusing the billionaire of defrauding shareholders of his investment company Icahn Enterprises ( IEP ) so he could obtain large amounts of personal loans. The lawsuit followed a May 2023 report by the short-selling firm Hindenburg Research that questioned whether Icahn's company inflated its...
Altria Group Unusual Options Activity
Altria Group Unusual Options Activity
Sep 16, 2024
Investors with a lot of money to spend have taken a bearish stance on Altria Group ( MO ) . And retail traders should know. We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know. But when something this...
Copyright 2023-2026 - www.financetom.com All Rights Reserved